Human Molecular Genetics, 2002, Vol. 11, No. 19 2279-2287
© 2002 Oxford University Press
Modulation of polyglutamine-induced cell death by genes identified by expression profiling
1Taisho Laboratory of Functional Genomics, Nara Institute of Science and Technology, 2Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, 8916-5 Takayama, Ikoma, Nara, 630-0101, Japan and 3Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2XY, UK
Received May 6, 2002; Accepted July 9, 2002
The majority of triplet-repeat diseases are caused by mutated genes with an extended polyglutamine tract, exemplified by Huntington's disease (HD). In order to model HD pathogenesis in a controlled system, we developed stable PC12 cell lines that express exon 1 fragments of the huntingtin gene with 23 or 74 polyglutamines driven by an inducible doxycycline (dox)-sensitive promoter (HD-23Q or HD-74Q). We aimed to identify early perturbations induced by the mutation by studying expression levels of 1824 genes at 0, 5, 10 and 18 hours after induction, using adaptor-tagged competitive PCR (ATAC–PCR). At these time points, the cells show no appreciable death or mitochondrial impairment and very low inclusion levels. A total of 126 genes, including 69 known genes, exhibited statistically significant alterations in the HD-74Q cell lines but no changes in the HD-23Q lines. We tested 11 of these genes for their abilities to modulate polyglutamine-induced cell death in transiently transfected cell models. Five genes [glucose transporter 1 (Glut1), phosphofructokinase muscle isozyme (Pfkm), prostate glutathione-S -transferase 2 (Gstm2), RNA-binding motif protein 3 (Rbm3) and KRAB-A interacting protein 1 (Krip-1)] significantly suppressed cell death in both neuronal precursor and non-neuronal cell lines, suggesting that these transcriptional changes were relevant to polyglutamine pathology. The efficient recovery of functionally relevant genes supports the utility of gene expression profiling for discovering pathways related to pathogenesis, and the importance of analyzing molecular events in the early stages of disease.
* To whom correspondence should be addressed. Tel: +81 743725583; Fax: +81 743725589; Email: kkato{at}bs.aist-nara.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Eto, K. Eda, M. Hayano, S. Goto, K. Nagao, T. Kawasaki, H. Kashimura, H. Tarui, O. Nishimura, K. Agata, et al. Reduced Expression of an RNA-binding Protein by Prolactin Leads to Translational Silencing of Programmed Cell Death Protein 4 and Apoptosis in Newt Spermatogonia J. Biol. Chem., August 28, 2009; 284(35): 23260 - 23271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Futter, H Diekmann, E Schoenmakers, O Sadiq, K Chatterjee, and D C Rubinsztein Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors J. Med. Genet., July 1, 2009; 46(7): 438 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Dupont-Versteegden, R. Nagarajan, M. L. Beggs, E. D. Bearden, P. M. Simpson, and C. A. Peterson Identification of cold-shock protein RBM3 as a possible regulator of skeletal muscle size through expression profiling Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1263 - R1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Pearson, T. J. Robinson, M. J. Munoz, A. R. Kornblihtt, and M. A. Garcia-Blanco Identification of the Cellular Targets of the Transcription Factor TCERG1 Reveals a Prevalent Role in mRNA Processing J. Biol. Chem., March 21, 2008; 283(12): 7949 - 7961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dresios, A. Aschrafi, G. C. Owens, P. W. Vanderklish, G. M. Edelman, and V. P. Mauro Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis PNAS, February 8, 2005; 102(6): 1865 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Li and X.-J. Li Huntington and its Role in Neuronal Degeneration Neuroscientist, October 1, 2004; 10(5): 467 - 475. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Minamiyama, M. Katsuno, H. Adachi, M. Waza, C. Sang, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, and G. Sobue Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Hum. Mol. Genet., June 1, 2004; 13(11): 1183 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wellmann, C. Buhrer, E. Moderegger, A. Zelmer, R. Kirschner, P. Koehne, J. Fujita, and K. Seeger Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism J. Cell Sci., May 1, 2004; 117(9): 1785 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ravikumar, A. Stewart, H. Kita, K. Kato, R. Duden, and D. C. Rubinsztein Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy Hum. Mol. Genet., May 1, 2003; 12(9): 985 - 994. [Abstract] [Full Text] [PDF]
|
|